Drug Research

Fast Track Designation granted to Concert Pharmaceutical’s CTP-543 for Alopecia Areata

Read more

Fresenius Kabi Launches Bortezomib injection in U.S

Read more

FDA approves GSK’s FLUARIX QUADRIVALENT

Read more

FDA sanctions use of Lynparza to treat Breast Cancer with inherited genetic mutation

Read more

LivaNova PLC commences BELIEVE Aortic Heart Valve Study

Read more

U.S FDA sanctions Boston Scientific Corporation’s Spectra WaveWriter SCS System

Read more

Adimab partners with Boehringer Ingelheim to optimize antibodies against targets

Read more

US FDA accepts Morphotek’s IND application for MORAb-202

Read more

ALK Introduces ODACTRA for house dust mite (HDM)-induced allergic rhinitis patients

Read more

AstraZeneca declared availability of BYDUREON BCise for Type-2 Diabetes

Read more